FOLLOW US 

  • White Twitter Icon
  • White YouTube Icon

Copyright © 2018 European Medical Group LTD. All rights reserved. Copyright © 2018 European Medical Group LTD. All rights reserved. Gold & EMG-Health is for informational purposes and should not be considered medical advice, diagnosis or treatment recommendation.

Terms and Conditions 

  • EMG

Achieving gender parity in the pharmaceutical industry still has a way to go, but many companies are making significant strides towards this. Our infographic showcases a handful of standout examples from the industry and explores key milestones in the history of women in the workplace.

The drugs sales market is an ever-evolving landscape, especially today as the market fragments, and individualised therapies start to make their mark. In this infographic, we showcase how these trends are forecast to impact drugs sales by the year 2024, emphasising key differences with the 2018 figures, as well as predicting which therapeutic areas are set to take home the biggest sales.

In the 110 years since Paul Ehrlich discovered the first modern antibiotic, a wealth of information on antimicrobial resistance has come to the forefront. Our infographic takes a look over the history of antibiotics and pharma’s role in its story.

Investigation into cell therapies is growing at an exponential rate across the pharma industry. In this infographic, we display the number and types of cell therapies currently in the R&D pipeline, with a particular analysis of CAR T

cell therapy.

2018 was a banner year for novel drug approvals. In this infographic we display an overview of drugs approved by the FDA and EMA, with special recognition of the orphan drugs that were brought to market in 2018. 

On Thursday 23 June 2016, the people of the UK voted to leave the EU, by a winning margin of 3.8%. There began the UK’s long and eventful route to leave, scheduled for Friday 29 March.
In this immersive infographic we mark important milestones the UK life-sciences sector has seen in this near 3-year period, and the events unfolding for the UK’s journey out of the EU.

We review some of the top selling biologics still to come off patent in the EU and US, and their respective biosimilars in the pipeline.

We reflect on pharma’s past year and some of the major events that took place.

Uncover the top selling drugs from 2017 and be enlightened on which drugs are projected to be the highest sellers of 2024.

Find out about the top pharma M&A's over the last 7 years, and which countries are leading the way.

YOU MIGHT ALSO LIKE.. 

Marketing

How to Save Lives, and not Alienate People

In the mission to develop drugs and treat patients, adoption and adherence inertia are curious eventualities. Could behavioural science translate them into a language we can all understand?

Tech/Digital

Hey Siri, Can I Trust You with My Health?

Health technology is taking off, but pharma is trailing in the shadows of big tech companies. It is time for pharma to harness its clinical expertise and innovate disease management tools for patients.

Medical Affairs

Harnessing the Power of Thought Leaders

Time is ripe for the pharmaceutical industry to expand their relationships with thought leaders to engage healthcare professionals on a much larger scale.

Never miss an update, subscribe!